You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 15, 2025

Patent: 10,272,050


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,272,050
Title:Nanoparticles and methods of use
Abstract: This disclosure relates to nanoparticles, compositions, methods of making, and methods of use thereof.
Inventor(s): Farokhzad; Omid C. (Waban, MA), Choi; Won Il (Cambridge, MA), Andrian; Ulrich von (Chestnut Hill, MA), Kamaly; Nazila (Boston, MA)
Assignee: The Brigham and Women\'s Hospital, Inc. (Boston, MA) President and Fellows of Harvard College (Cambridge, MA)
Application Number:15/519,052
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of United States Patent 10,272,050

Introduction to Patent Law in the United States

Patents in the United States are governed by the Patent Act (35 U.S. Code), which established the United States Patent and Trademark Office (USPTO). This framework is crucial for understanding the scope and claims of any patent, including United States Patent 10,272,050[1].

Patent 10,272,050 Overview

To analyze the scope and claims of United States Patent 10,272,050, one must first identify the invention and the claims made within the patent. Here are the key steps and considerations:

Identifying the Invention

The patent specification describes the invention in detail, including its purpose, components, and how it operates. For Patent 10,272,050, this involves reviewing the abstract, background of the invention, and the detailed description to understand what the patent covers.

Understanding Patent Claims

Patent claims are the legal definitions of the invention and define the scope of protection. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Statutory Categories Under Section 101

To ensure the patent is valid, it must fall within one of the four statutory categories under Section 101 of the Patent Act: processes, machines, manufactures, or compositions of matter, or any improvement thereof. The claims must also avoid non-statutory exceptions such as abstract ideas, natural phenomena, and laws of nature[1].

Analyzing Claim Eligibility

The eligibility of the claims under Section 101 is a critical step. This involves the Alice test, which is a two-step process:

  • Step One: Determine whether the claim is directed to a judicial exception (e.g., abstract idea, natural phenomenon).
  • Step Two: If the claim is directed to a judicial exception, determine whether the claim elements, considered both individually and as an ordered combination, add enough to transform the nature of the claim into a patent-eligible application of that exception[1].

Claim Scope and Breadth

The scope of the claims can be measured using metrics such as independent claim length and independent claim count. Narrower claims are often associated with a higher probability of grant and a shorter examination process compared to broader claims[3].

Reissue and Continuation Applications

If the patent holder seeks to modify the claims after the patent is granted, they must comply with the "original patent" requirement under 35 U.S.C. § 251. This means the reissue claims must be directed to the invention disclosed in the original patent and cannot introduce new subject matter that was not originally disclosed[5].

Searching and Analyzing Patent Documentation

To fully understand the patent landscape, one can use resources provided by the USPTO such as the Global Dossier, Public Search Facility, and Patent Assignment Search. These tools allow users to access file histories, patent families, and other relevant documentation[4].

Global Dossier and Public Search Facilities

The Global Dossier provides access to file histories of related applications from participating IP Offices, allowing users to see the patent family and related applications. The Public Search Facility in Alexandria, VA, offers additional resources, including trained staff to assist in searching patent and trademark information[4].

Patent Assignment and Ownership

Changes in ownership or assignments of the patent can be searched through the Patent Assignment Search website. This is crucial for understanding the current legal status and ownership of the patent[4].

Legal and Policy Considerations

The legal and policy landscape surrounding patents is constantly evolving. For example, studies on the feasibility of a small claims patent court highlight the need for efficient and cost-effective mechanisms for resolving patent disputes, which can impact the overall patent landscape[2].

Key Takeaways

  • Patent Claims: The claims define the scope of protection and must be carefully drafted to ensure they fall within statutory categories and avoid judicial exceptions.
  • Claim Eligibility: The Alice test is crucial for determining the eligibility of claims under Section 101.
  • Scope and Breadth: Narrower claims are generally preferred for a smoother examination process.
  • Reissue and Continuation: Any modifications to claims after grant must comply with the "original patent" requirement.
  • Search and Analysis: Utilize USPTO resources to understand the patent landscape and current legal status.

FAQs

Q: What are the statutory categories under Section 101 of the Patent Act? A: The statutory categories include processes, machines, manufactures, or compositions of matter, or any improvement thereof[1].

Q: How is the eligibility of patent claims determined under Section 101? A: The eligibility is determined using the Alice test, a two-step process that checks for judicial exceptions and whether the claim elements add enough to transform the nature of the claim[1].

Q: What is the significance of the "original patent" requirement in reissue applications? A: The reissue claims must be directed to the invention disclosed in the original patent and cannot introduce new subject matter[5].

Q: How can one search for patent documentation and file histories? A: Use the Global Dossier, Public Search Facility, and other resources provided by the USPTO[4].

Q: Why is the scope of patent claims important? A: The scope of claims affects the probability of grant and the length of the examination process, with narrower claims generally being more favorable[3].

Sources

  1. BitLaw - Patent Law in the United States
  2. ACUS - U.S. Patent Small Claims Court
  3. SSRN - Patent Claims and Patent Scope
  4. USPTO - Search for Patents
  5. Court of Appeals for the Federal Circuit - In Re FLOAT'N'GRILL LLC

More… ↓

⤷  Try for Free

Details for Patent 10,272,050

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 October 28, 1982 10,272,050 2034-10-14
Eli Lilly And Company HUMULIN R U-500 insulin human Injection 018780 December 29, 2015 10,272,050 2034-10-14
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 August 06, 1998 10,272,050 2034-10-14
Eli Lilly And Company HUMULIN R U-500 insulin human Injection 018780 March 31, 1994 10,272,050 2034-10-14
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 May 25, 2018 10,272,050 2034-10-14
Novo Nordisk Inc. NOVOLIN R insulin human Injection 019938 June 25, 1991 10,272,050 2034-10-14
Novo Nordisk Inc. NOVOLIN R insulin human Injection 019938 June 01, 2018 10,272,050 2034-10-14
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.